Revenue (Annual) Chart

View Revenue (Annual) for MTLZF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1987. Start Trial.
Date Value
December 31, 2025 234.34M
December 31, 2024 321.82M
December 31, 2023 550.51M
December 31, 2022 676.33M
December 31, 2021 723.95M
December 31, 2020 877.40M
December 31, 2019 1.203B
December 31, 2018 1.195B
December 31, 2017 951.67M
December 31, 2016 953.60M
December 31, 2015 942.50M
December 31, 2014 987.21M
December 31, 2013 953.33M
December 31, 2012 891.90M
December 31, 2011 950.27M
December 31, 2010 798.39M
December 31, 2009 709.42M
December 31, 2008 727.63M
December 31, 2007 523.22M
December 31, 2006 446.30M
Date Value
December 31, 2005 424.60M
December 31, 2004 405.40M
December 31, 2003 345.14M
December 31, 2002 297.45M
December 31, 2001 270.51M
December 31, 2000 264.56M
December 31, 1999 300.12M
December 31, 1998 286.68M
December 31, 1997 265.43M
December 31, 1996 299.78M
December 31, 1995 310.47M
December 31, 1994 259.49M
December 31, 1993 216.22M
December 31, 1992 269.30M
December 31, 1991 268.41M
December 31, 1990 222.30M
December 31, 1989 165.57M
December 31, 1988 166.15M
December 31, 1987 136.07M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Alcon AG 10.40B
Ypsomed Holding AG 910.71M
Straumann Holding AG 3.137B
Medacta Group SA 771.75M
Medartis Holding AG 324.22M